PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 12, 2025Scientific Reports2 citationsOpen Access

Effectiveness of rehabilitation dose heterogeneity for improving functional outcomes of patients with acute stroke: a nationwide observational study

View Full Paper
TTTakuaki TaniMKMasashi KanaiMKMasatoshi Kamada

Key Points

  • To assess how increased rehabilitation intensity affects functional outcomes in ischemic stroke patients and identify which patients benefit most.
  • Analyzed data from 39,140 propensity score-matched ischemic stroke patients
  • Compared those receiving ≥ 60 min of rehabilitation to those with lower doses
  • Utilized a causal forest model for estimating individualized treatment effectiveness
  • Patients in the highest-benefit quartile improved function significantly by +17.1%
  • Severe baseline ADL impairment, age, and fewer comorbidities were associated with greater benefit
  • Conversely, the lowest-benefit quartile experienced reduced functional outcomes, improving by -16.5%

Abstract

To examine heterogeneity in the impact of increased early rehabilitation intensity and to identify which ischemic stroke patients benefit most. We analysed 39,140 propensity score-matched ischemic stroke patients using Diagnosis Procedure Combination database. Patients who received ≥ 60 min of daily rehabilitation within the 14 hospital days were compared with those who received less, in terms of achieving a modified Rankin Scale (mRS) score of 0, 1, or 2 at 60 days. We employed a causal forest model to estimate individualized treatment effectiveness and assessed for heterogeneity in rehabilitation impact across subgroups. Patients in the highest-benefit quartile showed substantial functional improvement (mean Conditional Average Treatment Effect: +17.1%; 95% CI, 15.3-19.0%), characterized by severe baseline activities of daily living (ADL) impairment, age, fewer comorbidities, higher socioeconomic status, better consciousness, and higher rates of reperfusion therapy. Conversely, patients in the lowest-benefit quartile, typically older with moderate ADL impairment, high comorbidities, low socioeconomic status, and limited reperfusion therapy, showed minimal or negative benefit (-16.5%; 95% CI, -18.1% to -14.9%). Rehabilitation dosing impact varied substantially regarding functional ability, with patients having severe strokes, age, fewer comorbidities, and better baseline consciousness deriving the greatest benefit from increased rehabilitation dosing.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tani et al. (2025) studied this question.

synapsesocial.com/papers/694019032d562116f28f6180https://doi.org/10.1038/s41598-025-32006-w
Ask AI
Helpful
Bookmark
Share
View Full Paper